摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,4s)-4-氟-2-甲氧基羰基吡咯烷盐酸盐 | 58281-79-1

中文名称
(2S,4s)-4-氟-2-甲氧基羰基吡咯烷盐酸盐
中文别名
(4S)-4-氟-L-脯氨酸甲酯盐酸盐
英文名称
(2S,4S)-methyl 4-fluoropyrrolidine-2-carboxylate hydrochloride
英文别名
(2S,4S)-methyl 4-fluoropyrrolidin-2-carboxylate hydrochloride;methyl (2S,4S)-4-fluoro-pyrrolidine-2-carboxylate hydrochloride;Methyl (2S,4S)-4-fluoropyrrolidine-2-carboxylate hydrochloride;(2S,4S)-4-fluoro-2-(methoxycarbonyl)pyrrolidine hydrochloride;methyl (4S)-4-fluoro-L-prolinate hydrochloride;methyl (2S,4S)-4-fluoropyrrolidine-2-carboxylate;hydrochloride
(2S,4s)-4-氟-2-甲氧基羰基吡咯烷盐酸盐化学式
CAS
58281-79-1
化学式
C6H10FNO2*ClH
mdl
MFCD06738456
分子量
183.61
InChiKey
SJLXDUCYXKAYFC-FHAQVOQBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.21
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.833
  • 拓扑面积:
    38.3
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302,H317,H319
  • 储存条件:
    室温、密闭保存,并保持干燥。

SDS

SDS:a11d520bbd1824976b5ef784ad9a18ce
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: (2S,4S)-Methyl 4-fluoropyrrolidine-2-carboxylate hcl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: (2S,4S)-Methyl 4-fluoropyrrolidine-2-carboxylate hcl
CAS number: 58281-79-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H10FNO2.ClH
Molecular weight: 183.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    (2S,4s)-4-氟-2-甲氧基羰基吡咯烷盐酸盐乙酰氧基乙酰氯三乙胺 作用下, 以 乙腈 为溶剂, 反应 1.5h, 生成 methyl (2S,4S)-4-fluoro-1-(2-hydroxyacetyl)pyrrolidine-2-carboxylate
    参考文献:
    名称:
    EP1995237
    摘要:
    公开号:
  • 作为产物:
    描述:
    N-Boc-顺式-4-氟-L-脯氨酸甲酯盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 2.0h, 以400 mg的产率得到(2S,4s)-4-氟-2-甲氧基羰基吡咯烷盐酸盐
    参考文献:
    名称:
    [EN] 1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS
    [FR] DÉRIVÉS DE 1-(CYCLOPENT-2-EN-1-YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHÉNYL)-URÉE UTILISÉS COMME INHIBITEURS DE CXCR2
    摘要:
    这项发明涉及1-(3-磺酰基苯基)-3-(环戊-2-烯-1-基)脲衍生物,以及它们在治疗或预防由CXCR2受体介导的疾病和症状中的应用。此外,该发明涉及含有这些衍生物的组合物和它们的制备方法。
    公开号:
    WO2015181186A1
点击查看最新优质反应信息

文献信息

  • [EN] MACROCYCLIC AMIDES AS PROTEASE INHIBITORS<br/>[FR] AMIDES MACROCYCLIQUES EN TANT QU'INHIBITEURS DE PROTÉASE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2013104613A1
    公开(公告)日:2013-07-18
    The invention relates to a compound of formula (I) wherein A, B, D and R1 to R6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
    这项发明涉及一种化合物,其化学式为(I),其中A、B、D以及R1到R6的定义如描述和索赔中所述。化合物的化学式(I)可用作药物。
  • CYCLIC AMIDES
    申请人:HOFFMANN-LA ROCHE INC.
    公开号:US20130196965A1
    公开(公告)日:2013-08-01
    The invention relates to a compound of formula (I) wherein A, B, D and R 1 to R 6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
    这项发明涉及一种化合物,其化学式为(I),其中A、B、D和R1至R6如描述和权利要求中所定义。化合物的化学式(I)可用作药物。
  • BICYCLIC PYRAZOLE DERIVATIVE
    申请人:Dainippon Sumitomo Pharma Co., Ltd.
    公开号:EP1659123A1
    公开(公告)日:2006-05-24
    A compound represented by the following formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of either. These are compounds having high DPP-IV inhibitory activity and improved in safety, nontoxicity, etc. (I) [In the formula, R1 represents hydrogen, optionally substituted alkyl, etc.; the solid line and dotted line between A1 and A2 indicate a double bond (A1=A2), etc.; A1 represents a group represented by the formula C(R2), etc.; A2 represents a group represented by the formula C(R4), etc.; R2 represents hydrogen, optionally substituted alkyl, etc.; R4 represents hydrogen, optionally substituted alkyl, etc.; R6 represents hydrogen, optionally substituted aryl, etc.; and -Y represents, e.g.; a group represented by the formula (A): (A) (wherein ml is 0, 1, 2, or 3; and R7 is absent, or one or two R7's are present and each independently represents optionally substituted alkyl, etc.).]
    以下式(I)表示的化合物、前药或药用可接受的盐。这些化合物具有高DPP-IV抑制活性,并且在安全性、非毒性等方面进行了改进。(I) [在公式中,R1代表氢,可选地取代烷基等;A1和A2之间的实线和虚线表示双键(A1=A2)等;A1代表由公式C(R2)等表示的基团;A2代表由公式C(R4)等表示的基团;R2代表氢,可选地取代烷基等;R4代表氢,可选地取代烷基等;R6代表氢,可选地取代芳基等;-Y代表例如;由公式(A)表示的基团:(A)(其中ml为0、1、2或3;R7缺失,或存在一个或两个R7,每个独立地代表可选地取代烷基等)。]
  • [EN] METHODS FOR PREPARING FLUOROALKYL ARYLSULFINYL COMPOUNDS AND FLUORINATED COMPOUNDS THERETO<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS FLUOROALKYLE ARYLSULFINYLÉS ET COMPOSÉS FLUORÉS APPARENTÉS
    申请人:IM & T RES INC
    公开号:WO2010022001A1
    公开(公告)日:2010-02-25
    Novel preparative methods for fluoroalkyl arylsulfinyl compounds are disclosed. Fluorinated compounds as useful fluorinated compounds, intermediates, or builing blocks are disclosed. Useful applications of the fluoroalkyl arylsulfinyl compounds are shown.
    揭示了用于制备氟烷基芳基磺酰基化合物的新型制备方法。公开了氟化合物作为有用的氟化合物、中间体或构建块。展示了氟烷基芳基磺酰基化合物的有用应用。
  • Process for Producing Aminoacetyl Pyrrolidine Carbonitrile Derivative and Intermediate for Production Thereof
    申请人:Asahina Yoshikazu
    公开号:US20090048454A1
    公开(公告)日:2009-02-19
    Novel intermediates for the production of aminoacetyl pyrrolidine carbonitrile derivatives ensure the safe and efficient production of the compounds. Specifically, the present invention provides a sulfonyloxyacetyl pyrrolidine derivative, represented by the following formula: (Chemical Formula 1) (wherein R1 is a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 3 -C 6 cycloalkyl group, a substituted or unsubstituted arylmethyl group, a substituted or unsubstituted aromatic hydrocarbon, a substituted or unsubstituted aromatic heterocyclic ring or a substituted or unsubstituted aliphatic heterocyclic ring; R2 is CONH 2 or CN; and X is CH 2 , CHF or CF 2 .)
    新型中间体可用于生产氨基乙酰吡咯烷碳腈衍生物,确保化合物的安全高效生产。具体来说,本发明提供了一种磺酰氧乙酰吡咯烷衍生物,其化学式如下:(化学式1)(其中,R1是取代或未取代的C1-C6烷基,取代或未取代的C3-C6环烷基,取代或未取代的芳基甲基,取代或未取代的芳香烃,取代或未取代的芳香杂环环或取代或未取代的脂肪族杂环环;R2是CONH2或CN;X是CH2,CHF或CF2。)
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物